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Introduction: By the summer of 2014, the Syrian crisis resulted in a regional humanitarian emergency with
2.9 million refugees, including 608,000 in Jordan. These refugees access United Nations High Commissioner for
Refugees (UNHCR)-sponsored clinics or Jordan Ministry of Health clinics, including tuberculosis diagnosis and
treatment. Tuberculosis care in Syria has deteriorated with destroyed health infrastructure and drug supply chain.
Syrian refugees may have undiagnosed tuberculosis; therefore, the UNHCR, the International Organization for
Migration (IOM), the National Tuberculosis Program (NTP), and the Centers for Disease Control and Prevention
developed the Public Health Strategy for Tuberculosis among Syrian Refugees in Jordan. This case study presents
that strategy, its impact, and recommendations for other neighboring countries.
Case description: UNHCR determined that World Health Organization (WHO) criteria for implementing a
tuberculosis program in an emergency were met for the Syrian refugees in Jordan. Jordan NTP assessed their
tuberculosis program and found that access to Syrian refugees was the one component of their program missing.
Therefore, a strategy for tuberculosis control among Syrian refugees was developed. Since that development
through work with IOM, UNHCR, and NTP, tuberculosis case detection among Syrian refugees is almost 40 %
greater (74 cases/12 months or 1.01/100,000 monthly through June 2014 vs. 56 cases/16 months or 0.73/100,000
monthly through June 2013) using estimated population figures; more than two fold the 2012 Jordan tuberculosis
incidence. Additionally, the WHO objective of curing ≥85 % of newly identified infectious tuberculosis cases was
met among Syrian refugees.
Discussion and evaluation: Tuberculosis (TB) rates among displaced persons are high, but increased detection is
possible. High TB rates were found among Syrian refugees through active screening and will probably persist as the
Syrian crisis continues. Active screening can detect tuberculosis early and reduce risk for transmission. However, this
strategy needs sustainable funding to continue and all activities have not been realized.
Conclusions: Initial assessment found that tuberculosis among Syrian refugees was at a high incidence rate.
Through partnership, a cohesive Jordanian tuberculosis strategy was developed for Syrian refugees and it has
potential to inform treatment and control efforts for other regional countries impacted by the Syrian crisis.
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From March 2011 through July 2014, the Syrian crisis has
resulted in a regional humanitarian emergency with 2.9
million Syrian refugees, including 608,000 in Jordan [1]. In
Jordan, only 15 % of Syrian refugees are residing in camps;
the majority of refugees are integrated into host communi-
ties (non-camp refugees). Host community-based registered
and awaiting registration refugees are entitled to access
Hashemite Kingdom of Jordan Ministry of Health clinics
and United Nations High Commissioner for Refugees
(UNHCR)-sponsored clinics, respectively. These and camp-
based refugees have access to governmental chest clinics.
Prior to March 2011, Syria was making public health
gains in tuberculosis (TB) prevention, reducing annual
TB prevalence from 85 TB cases per 100,000 persons in
1990 to 23 per 100,000 in 2011 [2]. Tuberculosis care in
Syria was integrated in the healthcare system nationwide
with specialty TB treatment facilities located in each
governorate, including Aleppo and Homs, areas badly
destroyed by the conflict. As the conflict escalated,
health infrastructure has been destroyed, drug supply
chains have been interrupted, and healthcare workers
have fled [3, 4]; all negatively impacting TB diagnosis
and treatment efforts.
The Syrian refugee influx in Jordan resulted in TB pa-
tients seeking treatment at camp and non-camp clinics,
placing pressure on Jordan National TB Program (NTP)
resources. From March 2012 through June 2013, the
International Organization for Migration (IOM) and the
Jordan NTP confirmed 56 cases of TB among Syrian ref-
ugees, including 3 multidrug-resistant (MDR)-TB cases.
Therefore, with the technical assistance of the US Centers
for Disease Control and Prevention (CDC), the national
public health strategy was revised to target TB reduction
in this vulnerable population through development of the
Public Health Strategy for Tuberculosis among Syrian
Refugees in Jordan [5] in July 2013 by the NTP, UNHCR
and IOM with approval from the World Health
Organization-Jordan. This case study presents the strategy
and the impact of that strategy as well as recommenda-
tions for other neighboring countries.
Case description
The Jordan NTP reached the Millennium Development
Goal for TB reduction in 2011 and was preparing to
shift to TB elimination. However, TB elimination plan-
ning has been postponed because of the Syrian crisis
and refugee influx.
Criteria for implementing TB control programs
A poorly implemented TB control program can poten-
tially prolong the time a patient is infectious resulting in
greater transmission of TB. Therefore, the World Health
Organization (WHO) has outlined essential pre-requisitecriteria to meet before implementing TB programs in
emergencies [6].
These criteria include
1. Population data indicate TB is an important health
problem
2. Acute phase of the emergency is over
3. Population is stable for at least 6 months
4. Basic needs are met
5. Essential health care services and drugs for common
illnesses are available, and primary care health
services are accessible so that patients with
suspected TB can be identified, investigated, and
referred, if necessary.
In June 2013, IOM and CDC met with UNHCR and
WHO-Jordan to go point-by-point over these criteria to
determine if it was appropriate to offer TB care and con-
trol to Syrian refugees. For criterion 1, the TB prevalence
in Syria was three-fold higher than in Jordan for 2011;
23 per 100,000 persons in Syria compared with 7.7 per
100,000 persons for Jordan [2]. For criterion 2, “although
new arrivals continue in large numbers, mortality esti-
mates among refugees in Za’atri camp are well below
emergency levels and the health response has been
increasingly focused on chronic disease management”
[5]. For criterion 3, the Syrian crisis was in its third year
at the time of the convening of the partners. It was
expected that the population would remain in Jordan for
the unforeseen future, probably much longer than
6 months. For criteria 4 and 5, the Government of
Jordan, UNHCR, and other humanitarian actors have
established camps for the Syrian refugees as well as ser-
vices and support for non-camp refugees; these include
access to basic services, including food, and to essential
healthcare services. Therefore, these WHO criteria were
met in Jordan.Public health strategy
Despite challenges in providing stability and essential
services before implementing TB control in refugee
settings, the strength of the Jordan TB control program
offered a unique opportunity to improve refugee health,
prevent new TB cases through early detection and
reduced transmission, and minimize the emergence of
MDR-TB. In June 2013, IOM and CDC met with Jordan
NTP to develop a stepwise approach to ‘reduce suscep-
tible and resistant tuberculosis transmission, morbidity,
and mortality among Syrian refugees residing in Jordan’
[5]. The idea was that detection and treatment of TB
cases among Syrian refugees would continue to occur
through partnership of IOM and NTP, respectively, but
with a more systematic approach.
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their TB care and control program to determine if they
could adequately provide TB care and control for the
Syrian refugees. They examined their i) lead agency and co-
ordination; ii) policies, including the provision of directly
observed therapy short-course (DOTS) [7]; iii) availability
of human resources for the additional patient influx from
Syria; iv) access to the Syrian refugees; v) type (micro-
scopic, culture and drug-susceptibility testing capacity),
location and quality assurance of diagnostic laboratory fa-
cilities; vi) treatment regimens; vii) drug procurement and
storage; and viii) follow-up procedures. All of these were
found to be adequate except for the iv) access to the new
influx of Syrian refugees. Therefore, Jordan NTP wanted a
public health strategy developed to include Syrian refugees.
The strategic objectives were [5]:
1. Increase TB screening among Syrian refugees
initially processed in UNHCR camps, or among
those already residing in camp or non-camp
settings, by camp- or facility-based health
assessments, respectively
2. Increase TB diagnosis among Syrian refugees who
were patients with suspected TB. In addition,
identified refugees already with TB diagnosis with or
without receiving anti-TB treatment before arrival in
Jordan. IOM and/or NTP assessed these individuals
for the length of time without treatment, provided
additional testing, if needed, and then restarted on
treatment, if indicated. IOM with other health partners
conducted symptomatic TB screening of Syrian
refugees following the NTP diagnostic procedure and
all suspected cases received chest radiographs. If
radiographs were abnormal, three acid-fast bacilli
(AFB) smears and culture were performed to confirm
diagnosis. If the AFB results were negative and there
was no improvement after receiving non-TB antibiotics,
the diagnosis was based on radiograph finding and
medical officer’s judgment.
3. Maximize treatment success among Syrian refugees
for those remaining in Jordan or moving to other
countries. Four activities were undertaken: i) DOTS
was instituted using Jordan NTP case management
forms; ii) contingency plans for movement to other
countries for treatment were developed; however,
refugees were counseled to complete treatment in
Jordan and to sign a modified World Care Counsel
patient charter found in the CDC’s Evaluation Tool
for Tuberculosis Programs in Resource-limited,
Refugee and Post-Conflict Settings, version 2 [8].
For consenting patients, WHO and IOM agreed to
assist with transfers. At time of treatment initiation,
the refugee was given a DOTS card updated with
regimen administered, doses given, and pertinentlaboratory results, which s/he could take to other
treatment locations, either within Jordan or other
countries; iii) psychosocial support was provided by
the Jordanian Anti TB Association (JATA) to
increase treatment success, alleviate fears, and re-
duce stigma. TB patients often deal with stigma [9];
in addition, refugees have often witnessed traumatic
events and struggle with the consequences of
displacement adding to their need for psychosocial
support; and iv) ongoing monitoring and evaluation.
IOM collected TB cohort data and Jordan NTP
assessed their governorate and national diagnostic
TB centers using CDC’s TB program evaluation tool
for resource-limited and refugee settings [8]. For the
cohort analysis, the objectives were to verify that at least
85 % of the new smear-positive TB cases were cured.
4. Increase TB awareness and knowledge of treatment
services among Syrian refugees and their healthcare
providers by information, education and
communication (IEC) material for camp and
non-camp settings, and
5. Support the development and implementation of
national guidelines for management of latent TB
infection.
Each of the objectives had activities with indicators
and responsible partner(s) for collecting those indicators.
These indicators were collected by IOM and NTP and
shared with UNHCR and WHO.
Results of the public health strategy
The strategy was implemented in July 2013 (Fig. 1). Of
the five strategic objectives, objective 4: increase TB
awareness and knowledge of treatment services was to
ensure that the Syrian refugees with suspected TB could
enter the Jordan TB control program. This objective had
activities for refugees and for healthcare providers. IEC
material were developed for both groups to increase
awareness of TB signs and symptoms with messaging for
refugees that TB is curable and where to seek care if
someone had symptoms suggestive of TB. IOM con-
ducted hour-long TB awareness sessions in the camps
and community with the aid of a local medical associ-
ation and collected the numbers of refugees attending by
age group and sex. This strategy for the first 6 months
of 2014, resulted in almost 61,000 (10 % of total) Syrian
refugees attending IOM conducted TB awareness ses-
sions, with equal proportions of males and females
(Table 1). As far as anecdotal accounts, several refugees
presented to IOM reporting that they had TB signs and
symptoms after reading the IEC materials or attending
the awareness raising sessions, while others when asked
did not report having any sign and symptoms presum-
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Fig. 1 Timeline for implementing the TB strategy among Syrian refugees
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not captured).
Second in importance was objective 1: increase TB
screening, which offered Syrian refugees screening for
TB symptoms, and if present, chest radiography and
microscopic examinations, if indicated. With assistance
of Jordan NTP and with UNHCR for newly arriving ref-
ugees, IOM screened almost 69,000 (11 % of total popu-
lation) in first 6 months of 2014 (Table 1). Of those
Syrians screened through June 2014, 45 % were 14 years
of age or younger, which was comparable to the 45 % of
the Syrian refugees aged 0 through 14 years derived
from UNHCR regional demographic age structure [1].
Therefore, this suggests children were captured in the
TB screening efforts.Table 1 International Organization for Migration conducted TB awa
collaboration with the Jordan National TB Program among camp an
Total Total 2014 14-Jan 14-Feb
Awareness sessions 60,684 7,457 12,097
Male 30,465 3,942 6,242
% 50 % 53 % 52 %
Female 30,219 3,515 5,855
% 50 % 47 % 48 %
Screening 68,906 11,559 13,606
Male 33,160 5,667 6,482
% 48 % 49 % 48 %
Female 35,746 5,892 7,124
% 52 % 51 % 52 %
Under 15 years 30,886 4,792 6,787
% 45 % 41 % 50 %
Diagnosed 33 1 5
Male 19 0 3
% 58 % 0 % 60 %
Female 14 1 2
% 42 % 100 % 40 %For objective 3: maximize treatment success, IOM col-
lected, maintained, and reported TB data among Syrian
refugees. Examining the 2013-2014 TB cohort data for
Syrian refugees on treatment, for the first three quarters
(January-March 2013, April-June 2013, July-September
2013 followed for 9 months each), 91 %, 96 %, and 85 %
had completed their anti-TB treatment (or been cured)
for an overall completion rate of 91 % (Table 2), with
one death and no failures. For the first quarter, there
was a 9 % (two persons) treatment default rate; however,
zero for the following two cohort periods. These initial
two persons returned to Syria and were lost to follow-
up. Subsequently, IOM increased its assistance to the
refugees under treatment and emphasized with them the
importance of treatment completion before travelling.reness sessions, with TB screening and diagnosis performed in
d non-camp Syrian refugees, 2014
14-Mar 14-Apr 14-May 14-Jun
10,813 11,576 7,177 11,564
5,395 5,860 3,584 5,442
50 % 51 % 50 % 47 %
5,418 5,716 3,593 6,122
50 % 49 % 50 % 53 %
14,869 11,656 8,541 8,675
7,065 5,604 4,214 4,128
48 % 48 % 49 % 48 %
7,804 6,052 4,327 4,547
52 % 52 % 51 % 52 %
7,449 5,654 4,015 2,189
50 % 49 % 47 % 25 %
6 10 8 3
2 8 4 2
33 % 80 % 50 % 67 %
4 2 4 1
67 % 20 % 50 % 33 %
Table 2 Cohort results for 2014 of camp and non-camp Syrian refugee culture-confirmed patients who started anti-TB treatment
9 months prior
Tuberculosis cohort findings* by quarter, 2014 1st quarter % (n/N) 2nd quarter % (n/N) 3rd quarter % (n/N)
Cure/completion rate (without MDR†) 91 % (21/23) 96 % (23/24) 85 % (17/20)
Likely to complete treatment (without MDR) 91 % (21/23) 100 % (24/24) 95 % (19/20)
Death rate 0 % (0/0) 0 % (0/0) 5 % (1/20)
Default treatment rate 9 % (2/23) 0 % (0/0) 0 % (0/0)
Fail treatment rate 0 % (0/0) 0 % (0/0) 0 % (0/0)
*Source definitions: CDC. Understanding the TB cohort review process: instruction guide,
2006. [http://www.cdc.gov/tb/publications/guidestoolkits/cohort/method.htm]
†MDR, multiple-drug resistant
Table 4 Culture-confirmed TB cases identified among camp
and non-camp Syrian refugees in Jordan by timing of the
public health strategy, with rates based on population
estimates from UNHCR*
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6 months of 2014, of the 33 Syrian refugees with culture
confirmed active TB disease, one each was diagnosed in
Syria and Kuwait arriving with treatment and three were
diagnosed in Syria coming without any treatment; all five
once in Jordan received testing and appropriate treat-
ment begun or was continued. Only three were found to
be highly infectious with sputum smears containing
Mycobacterium tuberculosis bacilli identified microscop-
ically (smear-positive), 18 (78.3 %) were sputum smear-
negative, and two (6 %) were children under 5 years of
age (Table 3). The high percentage of smear-negative TB
cases was because a) some patients were partially treated
in Syria before coming to Jordan but were considered
new cases once in Jordan, and b) with the highly dy-
namic movement of refugees within Jordan and the fear
of losing cases, NTP increased the clinical diagnosis of
TB to include smear-negative TB cases who had three
additional criteria: (i) cough for more than 3 weeks, (ii)
no response to an non-TB antibiotics, and (iii) a chest
radiograph compatible with TB.
The public health strategy since initial development
has identified TB cases among Syrian refugees at a
higher rate (1.01 per 100,000 monthly or 12.17 per
100,000 for July 2013 through June 2014), than the pre-
strategy period (0.73 per 100,000 monthly or 8.75 per
100,000 for 12 months), or approximately 40 % greater,
using UNHCR population estimates (Table 4) [1]; more
than double the Jordan TB incidence (5.8 per 100,000)
for 2012 [10].Table 3 Culture-confirmed TB cases among camp and
non-camp Syrian refugees, through June 2014
Type/site of tuberculosis Case number
Pulmonary smear positive 3
Pulmonary smear negative 18
Pulmonary smear not available 2
Extra-pulmonary 10*
TOTAL 33
*2 among children less than 5 years of ageDiscussion and evaluation
Rising TB prevalence rates have been observed among
internally displaced persons within the Middle East and
Eurasia regions. The Iraqi TB prevalence of 94/100,000
population in 1990, dropped to 62/100,000 in 2000, but
rose to 74/100,000 in 2011 following years of armed
conflict [2]. In Bosnia and Herzegovina, new TB cases
increased 50 % over the wartime of the early 1990s [11].
After the independence of Georgia from the Soviet
Union, both latent TB infection and active disease were
common and screening, as currently offered in Jordan
for Syrian refugees, was found to be a useful tool to find
cases among that high prevalence population [12]. Add-
itionally, a systematic review of crisis-affected populations
(those experiencing displacement, armed conflict, or nat-
ural disasters) largely found elevated rates of TB notifica-
tion and of TB prevalence [13]. These reported higher
active TB rates probably developed over time and may be
seen as the Syrian crisis approaches its fourth year.
In the meantime, internally displaced Syrians are living
in a crisis situation. Living in a conflict zone may result
in delayed TB treatment and increased self-treatment
among TB patients as reported in other conflicts [14].
Drug-resistant TB has been found among resettling





TB cases 56 74
No. refugees at period end* 480,000 608,000
Months of period 16 12
Cases per month 3.50 6.17
Cases per month per 100,000
Syrian population
0.73 1.01
Cases per 12 months per 100,000 8.75 12.17
*Source: United Nations High Commissioner for Refugees: Syria Regional
Refugee Response [http://data.unhcr.org/syrianrefugees/regional.php]
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States [15–17]. Furthermore, interrupted TB treatment is
a risk factor for developing MDR-TB, carrying substantial
increased morbidity and mortality, and increased health-
care costs. Officials of the Jordan NTP noted that the
monthly cost of MDR-TB medication is Jordanian Dinar
(JOD) 2,000 versus JOD150 (over US$2,800 vs. US$210
monthly) for susceptible-TB medication; in addition,
MDR-TB treatment is 24 months [18].
Another reason for higher prevalence rates among refu-
gees may be because of increased detection. In the United
States, resettled refugees compared with immigrants are
offered free domestic health assessments [19]. This more
active system may lead to the higher TB prevalence seen
among refugees compared with other foreign-born per-
sons. This active screening and case detection are prob-
ably at play in the Jordanian Public Health TB Strategy.
The main challenges faced during the implementation
of the strategy, included
1. Syrian refugees are scattered in different
governorates of Jordan outside of the camp setting,
which made the screening process more challenging.
IOM used a mobile radiograph vehicle and worked
with NTP to conduct chest radiographs for
suspected cases.
2. Some TB patients did not comply with the DOTS
protocol and needed a close follow up to make sure
they were taking their medications. IOM visited
patients 5 times per week in the intensive phase and
3 times per week during the continuation phase.
3. Some of the extra-pulmonary TB patients suffered
from other co-morbid medical conditions/complica-
tions, such as epileptic seizures, vertebral deform-
ities, paralysis, urine incontinence, intestinal
obstruction, etc. and required costly medical inter-
ventions. IOM tried to coordinate with other health
providers that could provide appropriate assistance
and interventions.
4. Inside the camps, the stigma issue was higher than
outside the camps because of the overcrowded living
conditions. IOM tried to ensure the privacy of the
patients while raising awareness among refugees and
host community members who could assist in
overcoming the stigma.
Despite outlined challenges to TB control in refugee
settings, the strength of Jordan TB control program of-
fered a unique opportunity to improve refugee health,
prevent new TB cases, and minimize the emergence of
MDR-TB. There has been an almost 40 % increase in de-
tected TB case rate among the Syrian refugees in Jordan
since the TB strategy was implemented in July 2013
(while only a 25 % increase in the number of Syrianrefugees). Tuberculosis is often an unrecognized disease,
especially among children; therefore, providing screening
for both children and adults may allow for detection and
potentially at an earlier phase of the disease, understand-
ing that diagnosis among children is more difficult than
among adults [20]. Of those Syrians screened under the
public health strategy, the proportions who were children
were comparable with their proportion per UNHCR re-
gional demographic age structure. Of the Syrian refugees
with pulmonary TB, almost 80 % were sputum-smear
negative potentially attesting to less risk of transmission of
TB among the refugee as well as the host population.
However, no program is without limitations. Although,
the TB strategy has screened over 10 % of the Syrian
refugee population in the first 6 months of 2014, this
screening needs to continue to find refugees who have
been in the country since 2011. Furthermore, the calcu-
lated TB incidence of 12.2 per 100,000 per year for the
strategy is less than the WHO 2012 estimated incidence
rate of 18 (range 15-21) per 100,000 per year [10]. As
mentioned before as the crisis continues to unfold, the
incidence can only be expected to increase.
Additional limitations include the difficulties in se-
curing a steady line of funding to continue the strategy
over time. The CDC Evaluation Tool for Tuberculosis
Programs in Resource-limited, Refugee and Post-
Conflict Settings, version 2 has not been used at all
governorate chest clinics because of limited human
resource availability within the NTP. Although the
contingency plans for movement to other countries for
treatment were developed, they were not successfully
implemented because cross-border communication
with other national TB programs has not been suffi-
ciently established. National TB program guidelines
and practices are different in different countries. For
example, some countries provide free follow-up labora-
tory testing, while others in the region do not provide
such service. However, IOM in Jordan does work
closely with its other missions in the region informing
them when a refugee patient travels to their respective
country. IOM-Jordan obtains the patient’s contact de-
tails and provides these to the respective mission; that
mission then follows the patient until the completion of
his/her treatment course. Finally, protocol for the treat-
ment of latent TB infection still awaits development
and implementation.
Given the WHO objective for any TB control program
to cure at least 85 % of newly identified smear-positive
TB cases, the Jordan program for Syrian refugees is per-
forming to standards. These measures from TB aware-
ness to screening and diagnosis matched with treatment
activities specifically for Syrian refugees have ensured
this level of treatment success and should be considered
by neighboring countries.
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Jordan NTP, IOM, and UNHCR with technical assist-
ance of WHO and CDC have developed a cohesive strat-
egy to improve case detection and implement DOTS.
This public health strategy was integrated into the
Jordan NTP national strategy in December 2013. Initial
assessment of this strategy has found that both Syrian
children and adults are being diagnosed with TB at a
high incidence rate and probably leading to less trans-
mission of TB (only three sputum smear-positive pa-
tients) and less risk of drug-resistant TB. The public
health TB control strategy needs continued support and
strengthening to reach all Syrian refugees with potential
TB, especially those who arrived in the early months of
the crisis. However, this strategy attests to the import-
ance of active screening of arriving refugees and needs
to be considered in neighboring countries of the region
such as Iraq, Lebanon, and Turkey. A successful TB
strategy for Syrian refugees in Jordan has the potential
to inform future treatment and control efforts for other
regional countries impacted by the Syrian crisis.
Abbreviations
CDC: US Centers for Disease Control and Prevention; DOTS: Directly observed
therapy short-course; IEC: Information, education and communication;
IOM: International Organization for Migration; JOD: Jordanian Dinar;
MDR: Multidrug resistant; NTP: National Tuberculosis Program;
TB: Tuberculosis; UNHCR: United Nations High Commissioner for Refugees;
WHO: World Health Organization.
Competing interests
None of the authors have any competing interests. The funding for this
strategy are the authors’ agency of UNHCR; and the Jordan National
Tuberculosis Program (drugs, technical support and inpatient management),
the Canadian International Development Agency (CIDA), UN Central
Emergency Response Fund (CERF) and the Department of State, Bureau of
Population, Refugee and Migration (BPRM) had contributed to the project
since 2012. The findings and conclusions in this report are those of the
authors and do not necessarily represent the official position of the United
Nations High Commissioner for Refugees, Jordan National Tuberculosis
Program, International Organization for Migration, or the US Centers for
Disease Control and Prevention.
Authors’ contributions
All authors [(HA), (NO), (MN), International Organization for Migration,
Amman, Jordan; (AB), United Nations High Commissioner for Refugees,
Amman, Jordan; (KAR), (NAS), Hashemite Kingdom of Jordan National TB
Program, Amman, Jordan; (KRC), (STC), US Centers for Disease Control and
Prevention, Atlanta, GA, USA] have contributed to the manuscript. Especially,
HA collected, interpreted and disseminated the cohort data, participated in
drafting manuscript; KAR, MN, NO, NAS, and AB worked on strategy
development, participated in drafting manuscript; STC and KRC conceived of
the strategy and cohort design; STC coordinated and drafted the manuscript.
All authors read and approved the final manuscript.
Author details
1US Centers for Disease Control and Prevention, Atlanta, GA, USA.
2International Organization for Migration, Amman, Jordan. 3United Nations
High Commissioner for Refugees, Amman, Jordan. 4Hashemite Kingdom of
Jordan National TB Program, Amman, Jordan.
Received: 9 October 2014 Accepted: 1 May 2015References
1. United Nations High Commissioner for Refugees: Syria regional refugee
response. http://data.unhcr.org/syrianrefugees/regional.php. Accessed 8
Sept 2014.
2. World Health Organization: Global tuberculosis report, 2012. http://
www.who.int/tb/publications/global_report/en/. Accessed 26 Aug 2014.
3. Human Rights Council: Oral update of the Independent International
Commission of Inquiry on the Syrian Arab Republic, March 11, 2013.
http://www.ohchr.org/Documents/HRBodies/HRCouncil/CoISyria/
PeriodicUpdate11March2013_en.pdf. Accessed 26 Aug 2014.
4. UN News Centre: Syria experiencing critical shortage in medicines – WHO,
August 7, 2012. http://www.un.org/apps/news/story.asp?NewsID=42641.
Accessed 26 Aug 2014.
5. United Nations High Commissioner for Refugees: Public Health Strategy for
Tuberculosis among Syrian Refugees in Jordan, July 2013. http://
data.unhcr.org/syrianrefugees/download.php?id=3791. Accessed
26 Aug 2014.
6. World Health Organization: Tuberculosis care and control in emergencies,
April 2009. http://www.who.int/diseasecontrol_emergencies/publications/
idhe_2009_london_tuberculosis.pdf. Accessed 26 Aug 2014.
7. World Health Organization, 2009. Treatment of tuberculosis: guidelines for
national programmes, 4th edition. http://www.who.int/tb/dots/treatment/en/.
Accessed 26 Aug 2014.
8. Centers for Disease Control and Prevention: Evaluation Tool for Tuberculosis
Programs in Resource-limited, Refugee and Post-Conflict Settings, version 2.
http://www.cdc.gov/globalhealth/healthprotection/errb/researchandsurvey/
tbtool.htm. Accessed 18 Aug 2014.
9. Christodoulou M. The stigma of tuberculosis. Lancet Sept. 2011;11:663–4.
10. World Health Organization: Global tuberculosis report, 2013. http://
www.who.int/tb/publications/global_report/en. Accessed 7 Aug 2014.
11. Ljubic B, Hrabac B. Priority setting and scarce resources: case of the
Federation of Bosnia and Herzegovina. Croatian Med. 1998;39(3):276–80.
12. Weinstock DM, Hahn O, Wittkamp M, Sepkowitz KA, Khechinashvili G,
Blumberg HM. Risk for tuberculosis infection among internally displaced
persons in the Republic of Georgia. Int J Tuberc Lung Dis. 2001;5(2):164–9.
13. Kimbrough W, Saliba V, Dahab M, Haskew C, Checchi F. The burden of
tuberculosis in crisis-affected populations: a systematic review. Lancet
Infect Dis. 2012;12:950–65.
14. Gele AA, Bjune GA. Armed conflicts have an impact on the spread of
tuberculosis: the case of the Somali Regional State of Ethiopia. Confl Heal.
2010;4:1.
15. Callister MEJ, Barringer J, Thanabalasingam ST, Gair R, Davidson RN.
Pulmonary tuberculosis among political asylum seekers screened at
Heathrow Airport, London, 1995-9. Thorax. 2002;57:152–6.
16. Brudey K, Gordon M, Moström P, Svensson L, Jonsson B, Sola C, et al.
Molecular epidemiology of Mycobacterium tuberculosis in western Sweden.
J Clin Micro. 2004;42(7):3046–51.
17. Oseltmann JE, Varma JK, Ortega L, Liu Y, O’Rourke T, Cano M, et al.
Multidrug-resistant tuberculosis outbreak among US-bound Hmong
refugees, Thailand, 2005. Emerging Infect Dis. 2008;14(11):1715–21.
18. The Jordan Times, Mar 24, 2013, Malkawi K: High prevalence of TB among
Syrians to affect local efforts to eliminate it http://jordantimes.com/high-
prevalence-of-tb-among-syrians-to-affect-local-efforts-to-eliminate-it.
Accessed 18 Mar 2015.
19. Office of Refugee Resettlement. About cash & medical assistance. http://
www.acf.hhs.gov/programs/orr/programs/cma/about. Accessed 18 Mar 2015.
20. Perez-Velez CM, Marais BJ. Tuberculosis in children. New Engl J Med.
2012;367(4):348–61.
